You are here

Integrated Paper-Based Microfluidic Blood Analyzer for use in Austere Environments

Award Information
Agency: Department of Defense
Branch: Special Operations Command
Contract: D16PC00156
Agency Tracking Number: S161-002-0032
Amount: $149,998.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: SOCOM16-002
Solicitation Number: 2016.1
Timeline
Solicitation Year: 2016
Award Year: 2016
Award Start Date (Proposal Award Date): 2016-07-06
Award End Date (Contract End Date): 2017-01-05
Small Business Information
1845 West 205th Street
Torrance, CA 90501
United States
DUNS: 153865951
HUBZone Owned: No
Woman Owned: Yes
Socially and Economically Disadvantaged: No
Principal Investigator
 Ms. Mahsa Rohanizadeh, Ph.D.
 (310) 320-3088
 PSProposals@poc.com
Business Contact
 Mr. Gordon Drew
Phone: (310) 320-3088
Email: gedrew@poc.com
Research Institution
N/A
Abstract

To address USSOCOMs need for an environmentally stable, rapid, portable comprehensive blood analyzer system, Physical Optics Corporation (POC) proposes to develop a new Integrated Paper-Based Microfluidic Blood Analyzer for use in Austere Environments (iBLAdE) based on electrochemical measurements of different panels of electrolytes, metabolites, blood gases, and blood typing antigens within a microfluidic system. Specifically, the innovation in design and development of an electrochemical microfluidic system with ion selective electrodes and membranes will enable the iBLAdE system to accurately and rapidly provide a comprehensive analysis with high sensitivity and selectivity. As a result, this device offers stability, portability, and speed, which directly address SOCOM requirements. In Phase I, POC will demonstrate the iBLAdE by performing a feasibility study to investigate technology options that meet or exceed the minimum performance parameters, addressing the risks and potential drawbacks, and finalizing and validating the choices to be implemented in iBLAdE. Laboratory studies to finalize prototype configuration to be implemented in Phase II will include measuring concentrations of sodium, lactate, hematocrit, and blood/Rh typing, reaching technology readiness level (TRL)-3. In Phase II, POC plans to reach TRL-5 by further developing and validating the prototype.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government